USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AUGUSTA PHARMACEUTICALS, INC.
Address:
58 OAK CLIFF RD
NEWTONVILLE, MA 02460-
Phone:
N/A
URL:
N/A
EIN:
943444230
DUNS:
828453139
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $203,208.00 1

Award List:

DEVELOPMENT OF ROS KINASE INHIBITORS - PHASE I SBIR TOPIC 255

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$203,208.00
Agency:
HHS
Principal Investigator:
Dorre Grueneberg – (713) 798-8167
Abstract:
The Augusta founding laboratories have used cutting edge genetic technologies and shRNA screening methodologies to uncover the ROS receptor tyrosine kinase as a cancer survival gene. Studies from other laboratories have drawn a clear link between ROS kinase activity and the development and/or… More